Everolimus in patients with solid tumours.

Trial Profile

Everolimus in patients with solid tumours.

Phase of Trial: Phase I

Latest Information Update: 15 Nov 2010

At a glance

  • Drugs Everolimus (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 15 Nov 2010 New trial record
    • 12 Oct 2010 Results presented at the European Society for Medical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top